Literature DB >> 80838

HLA and Japanese MS.

S Naito, Y Kuroiwa, T Itoyama, T Tsubaki, A Horikawa, T Sasazuki, S Noguchi, S Ohtsuki, H Tokuomi, T Miyatake, N Takahata, S Kawanami.   

Abstract

Determination of HLA-A, -B and -C types in 43 Japanese patients with multiple sclerosis (MS) and of DR type in 25 MS patients was carried out using antisera from the 7th International Histocompatibility Workshop. The results were compared with 46 controls typed simultaneously. Twenty-three patients were also tested for HLA-Dw2. The conclusions were: 1) There were no significantly higher occurrences of HLA-A3, B7, Dw2 or DRw2 in Japanese MS. 2) Japanese MS might nevertheless be associated with the human major histocompatibility complex, because HLA-B40 was significantly less frequent in MS and two anti HLA-DRw sera, 7w008 and 034, reacted positively more often against lymphocytes from MS patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80838

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.

Authors:  N Morling; M Sandberg-Wollheim; L Fugger; J Georgsen; J J Hylding-Nielsen; H O Madsen; K Rieneck; L Ryder; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire.

Authors:  L Steinman
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  HLA and multiple sclerosis in Italy: a review of the literature.

Authors:  L La Mantia; M T Illeni; C Milanese; A Salmaggi; M Eoli; G Pellegris; A Nespolo
Journal:  J Neurol       Date:  1990-11       Impact factor: 4.849

4.  The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients.

Authors:  D Montanaro; V Sanna; G Matarese; B B Larby; L Racioppi; P B Carrieri; R Bruno; N J Davey; S Zappacosta; S Fontana
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

5.  HLA and prognosis in multiple sclerosis.

Authors:  B Runmarker; T Martinsson; J Wahlström; O Andersen
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

6.  Is the frequency of multiple sclerosis increasing in Mexico?

Authors:  O Gonzalez; J Sotelo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

7.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Authors:  A Valli; A Sette; L Kappos; C Oseroff; J Sidney; G Miescher; M Hochberger; E D Albert; L Adorini
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.

Authors:  R Martin; M D Howell; D Jaraquemada; M Flerlage; J Richert; S Brostoff; E O Long; D E McFarlin; H F McFarland
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

Review 9.  Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.

Authors:  B Gran; B Hemmer; M Vergelli; H F McFarland; R Martin
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.